Cell line · CVCL_6298
TPC-1
Cancer cell line, Homo sapiens. Thyroid gland papillary carcinoma. 53 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. TPC-1. Cell lines, record CVCL_6298. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_6298
On this page
Cell line
As Cellosaurus gives it.
- Name
- TPC-1
- Accession
- CVCL_6298
- RRID
- RRID:CVCL_6298
- Synonyms
- TPC1
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- Adult
- Category
- Cancer cell line
- Diseases
- Thyroid gland papillary carcinoma (NCIt C4035); Differentiated thyroid carcinoma (ORDO Orphanet_146)
- Derived from
- Thyroid gland (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers53
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 42997835 | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SUMOylation-Dependent Repression of BIRC7 by DNMT3a Suppresses Papillary Thyroid Carcinoma Progression. | Cell Biochem Funct | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Unveiling ER-Phagy Receptors in Thyroid Cancer: A Combined Approach of Public Data Mining and In Vitro Validation. | Clin Med Insights Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Loss of CSE couples with BRAF V600E to fuel thyroid cancer metastatic progression through zinc-dependent activation of the EMT machinery. | J Exp Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Modulation of chemokine secretion and oxidative stress in vitro in thyroid cells after exposure to thiocyanate, nitrate, or perchlorate. | Front Endocrinol (Lausanne) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sunitinib enhances cuproptosis induced by copper ionophores via ROS-ATF3-SLC31A1 axis in thyroid Carcinoma. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid Cancer. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of ATM reverses radioiodine resistance in differentiated thyroid cancer via genotoxic stress amplification. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bisphenol A Induces DNA Damage and Differential Cytotoxicity in Thyroid Cells: High-Dose Effects Challenge Regulatory Thresholds. | J Appl Toxicol | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 53
See all 53 papersRelatives9
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | BHP 10-3 | CVCL_6278 | Has a recorded problem | Cell lines |
| Derived from it | BHP 18-21 | CVCL_6282 | Has a recorded problem | Cell lines |
| Derived from it | BHP 2-7 | CVCL_6283 | Has a recorded problem | Cell lines |
| Derived from it | BHP 7-13 | CVCL_6285 | Has a recorded problem | Cell lines |
| Derived from it | FB-2 | CVCL_9917 | Has a recorded problem | Cell lines |
| Derived from it | HyCyte TPC-1 stable cell line for hLCN2 overexpression | CVCL_F4LL | Cell lines | |
| Derived from it | HyCyte TPC-1 stable cell line for hRPSAP52 overexpression | CVCL_F4WF | Cell lines | |
| Derived from it | HyCyte TPC-1-Luc | CVCL_E3IT | Cell lines | |
| Derived from it | RPTC-1 | CVCL_V277 | Has a recorded problem | Cell lines |
Cell banks4
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_6298
GET https://conductscience.org/api/cell-lines/v1/CVCL_6298/papers?page=2